| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,969 | 3,445 | 2,776 | | Cost of Revenue | 1,899 | 3,046 | 3,369 | | | Gross Profit | 1,070 | 399 | (593) | | | Operating Expenses | | Research Development | 2,316 | 5,315 | 6,238 | | Selling General and Administrative | 4,027 | 7,739 | 10,378 | | Non Recurring |
-
|
-
|
-
| | Others | 266 | 602 | 720 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,539) | (13,257) | (17,929) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,203) | 3,110 | 1,869 | | Earnings Before Interest And Taxes | (6,742) | (10,147) | (16,060) | | Interest Expense | 2,540 | 4,592 | 1,548 | | Income Before Tax | (9,282) | (14,739) | (17,608) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,282) | (14,739) | (17,608) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (9,282) | (14,739) | (17,608) | | Preferred Stock And Other Adjustments |
-
| (30) | (106) | | | Net Income Applicable To Common Shares | ($9,282) | ($14,769) | ($17,714) |
|
1.48% Nasdaq 
0.01 (1.12%) 
Income Statement
